Back

Should all menopausal women be prescribed hormone replacement therapy to reduce risk? - pro

30 August 2024 (16:15 - 16:30)
Organised by: Logo
Congress Presentation Part of: Great Debate: should all menopausal women be prescribed hormone replacement therapy to reduce risk? Cardiovascular Disease in Women ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Associate Professor Catherine Gebhard

Inselspital - University of Bern, Bern (Switzerland)

2 More presentations in this session

Presentation thumbnail
Should all menopausal women be prescribed hormone replacement therapy to reduce risk? - con
Professor M. Gulati (Houston, US)
Slides Video
Presentation thumbnail
Should all menopausal women be prescribed hormone replacement therapy to reduce risk? - discussion
Video

Access the full session

Session thumbnail
Great Debate: should all menopausal women be prescribed hormone replacement therapy to reduce risk?
Video

The Event

Event poster

ESC Congress 2024

30 August 2024 16:15 CET
You may be interested in
thumbnail
Congress Session
Great Debate: should all menopausal women be prescribed hormone replacement therapy to reduce risk?
thumbnail
Congress Presentation
Should all menopausal women be prescribed hormone replacement therapy to reduce risk? - discussion
thumbnail
Congress Presentation
Should all menopausal women be prescribed hormone replacement therapy to reduce risk? - con

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources